Financial News
Latest News about DNLI
Recent news which mentions DNLI
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
From Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
September 29, 2022
From Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
From Benzinga
From Motley Fool
From Benzinga
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
May 02, 2022
From MarketWatch
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
7 F-Rated Stocks to Avoid During the Downturn
March 23, 2022
From InvestorPlace
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
48 Biggest Movers From Yesterday
January 14, 2022
From Benzinga
Why Denali Therapeutics Stock Is Sinking This Week
January 13, 2022
From Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
January 13, 2022
From Benzinga
Mid-Afternoon Market Update: Nasdaq Dips 250 Points; Taiwan Semiconductor Shares Gain
January 13, 2022
From Benzinga
26 Stocks Moving In Thursday's Mid-Day Session
January 13, 2022
From Benzinga
From Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
Tickers
DNLI
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
From Benzinga
Jim Cramer Says This Stock Is 'Really Cheap'
December 16, 2021
From Benzinga
From Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
October 07, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2021
September 21, 2021
From Benzinga
President And CEO Of Denali Therapeutics Sold $1.00 Million In Stock
September 03, 2021
Tickers
DNLI
From Benzinga
My 2019 Report Card: Up 319%
August 15, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.